CARDIFF ONCOLOGY, INC. Deferred Tax Assets, Gross, Current
CARDIFF ONCOLOGY, INC. (CRDF) had Deferred Tax Assets, Gross, Current of $43.99 million as of 2019-12-31, per its 10-K filed 2020-02-27.
Discontinued › Notes › Income Taxes
us-gaap:DeferredTaxAssetsGrossCurrent · last filed 2020-02-27
- 2019-12-31: Deferred Tax Assets, Gross, Current $43.99M.
- 2018-12-31: Deferred Tax Assets, Gross, Current $41.04M.
- 2017-12-31: Deferred Tax Assets, Gross, Current $37.31M.
- 2016-12-31: Deferred Tax Assets, Gross, Current $50.26M; Deferred Tax Assets, Gross, Current as first filed $50.26K.
| Period end | Deferred Tax Assets, Gross, Current | Deferred Tax Assets, Gross, Current as first filed |
|---|---|---|
| 2019-12-31 | $43.99M 10-K · filed 2020-02-27 | |
| 2018-12-31 | $41.04M 10-K · filed 2020-02-27 | |
| 2017-12-31 | $37.31M 10-K · filed 2019-03-06 | |
| 2016-12-31 | $50.26M 10-K · filed 2018-02-26 | $50.26K 10-K · filed 2017-03-15 |
| 2015-12-31 | $34.00K 10-K · filed 2017-03-15 | $33.67M 10-K · filed 2016-03-10 |
| 2014-12-31 | $22.32M 10-K · filed 2016-03-10 | |
| 2013-12-31 | $16.22M 10-K · filed 2015-03-12 | |
| 2012-12-31 | $11.83M 10-K · filed 2014-03-17 | |
| 2011-12-31 | $9.83M 10-K · filed 2013-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B |